Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

BRAF-MEK inhibition in a giant BRAF-mutant Rathke cleft cyst: Diagnostic challenges and clinical implications for BRAF testing.

Neuro-oncology practice·2026
Same author

Efficacy of MAPK inhibitors in children with neurodegenerative Langerhans cell histiocytosis: Results from the European Consortium for Histiocytosis.

HemaSphere·2026
Same author

Efficacy and Tolerance of Cladribine for Non-Langerhans Cell Histiocytosis.

European journal of haematology·2026
Same author

Early brain biopsy in neurological diseases of unknown etiology improves functional outcome.

European journal of internal medicine·2026
Same author

Neurofilament as a biomarker of neurodegeneration in childhood Langerhans cell histiocytosis: A feasibility study on 273 patients.

British journal of haematology·2026
Same author

Biocatalytic production of odour-active fatty aldehydes via inherent rice seedling α-dioxygenase activity.

Journal of biotechnology·2026

Related Experiment Video

Updated: Aug 24, 2025

Optimized Analysis of DNA Methylation and Gene Expression from Small, Anatomically-defined Areas of the Brain
13:11

Optimized Analysis of DNA Methylation and Gene Expression from Small, Anatomically-defined Areas of the Brain

Published on: July 12, 2012

18.9K

Robust methylation-based classification of brain tumours using nanopore sequencing.

Luis P Kuschel1, Jürgen Hench2, Stephan Frank2

  • 1Department of Neurology with Experimental Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Neuropathology and Applied Neurobiology
|October 21, 2022
PubMed
Summary

Nanopore sequencing enables rapid and accurate DNA methylation classification of brain tumours. This cost-effective method provides high confidence for clinical neuro-oncology applications.

Keywords:
brain tumourepigenomicsmachine learningmolecular pathologynanopore sequencingwhole-genome sequencing

More Related Videos

Methyl-binding DNA capture Sequencing for Patient Tissues
08:40

Methyl-binding DNA capture Sequencing for Patient Tissues

Published on: October 31, 2016

8.7K
On-Site Sampling and Extraction of Brain Tumors for Metabolomics and Lipidomics Analysis
06:48

On-Site Sampling and Extraction of Brain Tumors for Metabolomics and Lipidomics Analysis

Published on: May 31, 2020

6.0K

Related Experiment Videos

Last Updated: Aug 24, 2025

Optimized Analysis of DNA Methylation and Gene Expression from Small, Anatomically-defined Areas of the Brain
13:11

Optimized Analysis of DNA Methylation and Gene Expression from Small, Anatomically-defined Areas of the Brain

Published on: July 12, 2012

18.9K
Methyl-binding DNA capture Sequencing for Patient Tissues
08:40

Methyl-binding DNA capture Sequencing for Patient Tissues

Published on: October 31, 2016

8.7K
On-Site Sampling and Extraction of Brain Tumors for Metabolomics and Lipidomics Analysis
06:48

On-Site Sampling and Extraction of Brain Tumors for Metabolomics and Lipidomics Analysis

Published on: May 31, 2020

6.0K

Area of Science:

  • Oncology
  • Genomics
  • Bioinformatics

Background:

  • DNA methylation profiling is crucial for cancer diagnosis, particularly in brain tumours.
  • Current microarray methods are time-consuming and expensive.
  • Shallow nanopore whole-genome sequencing offers a rapid, cost-effective alternative for DNA methylation profiling.

Purpose of the Study:

  • To evaluate the efficacy of nanopore sequencing for DNA methylation-based classification of a wide spectrum of primary brain tumours.
  • To establish a robust and rapid classification method for clinical neuro-oncology.

Main Methods:

  • Genome-wide DNA methylation profiling using shallow nanopore sequencing on 382 brain tumour samples.
  • Supervised classification using random forests with a minimum of 1000 CpG features.
  • Implementation of score recalibration and a platform-specific confidence threshold.

Main Results:

  • Nanopore sequencing successfully discriminated 46 brain tumour subtypes.
  • High-confidence classification was achieved with a minimum of 1000 CpG features.
  • The method demonstrated 80.4% sensitivity and 100% specificity in validation, with 90.9% concordance across four labs.
  • Median time to results was 21.1 hours in prospective benchmarking.

Conclusions:

  • Nanopore sequencing provides a robust and rapid method for methylation-based brain tumour classification.
  • Platform-specific confidence scores aid clinical interpretation.
  • Prospective evaluation is recommended for broader clinical implementation.